<< Read Full Article
<< Read Full Article
Health stocks followed the broader market higher Tuesday, rising on regulatory news and despite some Wall Street downgrades.
Invitrogen (IVGN Quote) shares rose $1.80, or 4.7%, to $40.47 after the Food and Drug Administration granted premarket approval to a genetic test that helps assess breast cancer patients for whom cancer drug Herceptin is being considered.
Meanwhile, ViroPharma (VPHM Quote) said Tuesday that the FDA has said the July 23 advisory committee meeting will not focus specifically on its Vancocin but rather the Office of Generic Drugs discuss with the committee generic-drug issues and how they apply to locally acting drugs that treat gastrointestinal conditions. ViroPharma shares rose 44 cents, or 4.1%, to $11.27. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,452.68 | 1,109.24 | 2,185.03 | 33.23 |
Oil *
77.73
|
|
DOWN
18.90
|
UP
0.38
|
UP
9.22
|
UP
0.48
|
10 Yr
3.32%
SPDR Gold
119.18
|
|
-0.18%
|
+0.03%
|
+0.42%
|
+1.47%
|
Data delayed 20 minutes |
Connect with TheStreet